BioDelivery Sciences International, Inc. (BDSI): Price and Financial Metrics

BioDelivery Sciences International, Inc. (BDSI)

Today's Latest Price: $3.82 USD

0.10 (2.69%)

Updated Nov 27 1:00pm

Add BDSI to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 389 in Biotech

See all "A" rated Strong Buy stocks

BDSI Stock Summary

  • Of note is the ratio of Biodelivery Sciences International Inc's sales and general administrative expense to its total operating expenses; 88.04% of US stocks have a lower such ratio.
  • In terms of twelve month growth in earnings before interest and taxes, Biodelivery Sciences International Inc is reporting a growth rate of -1,694.34%; that's higher than only 1.21% of US stocks.
  • As for revenue growth, note that BDSI's revenue has grown 49.25% over the past 12 months; that beats the revenue growth of 89.57% of US companies in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Biodelivery Sciences International Inc are ECOM, IVC, TESS, ENZ, and MATW.
  • BDSI's SEC filings can be seen here. And to visit Biodelivery Sciences International Inc's official web site, go to

BDSI Stock Price Chart Interactive Chart >

Price chart for BDSI

BDSI Price/Volume Stats

Current price $3.82 52-week high $7.21
Prev. close $3.72 52-week low $2.85
Day low $3.67 Volume 585,900
Day high $3.82 Avg. volume 1,064,509
50-day MA $3.68 Dividend yield N/A
200-day MA $4.21 Market Cap 386.24M

BioDelivery Sciences International, Inc. (BDSI) Company Bio

BioDelivery Sciences International, Inc. engages in the development and commercialization of pharmaceutical products principally in the areas of pain management and addiction. The company was founded in 1997 and is based in Raleigh, North Carolina.

BDSI Latest News Stream

Event/Time News Detail
Loading, please wait...

BDSI Latest Social Stream

Loading social stream, please wait...

View Full BDSI Social Stream

Latest BDSI News From Around the Web

Below are the latest news stories about Biodelivery Sciences International Inc that investors may wish to consider to help them evaluate BDSI as an investment opportunity.

BioDelivery Sciences International, Inc. (BDSI) Investor Presentation - Slideshow

The following slide deck was published by BioDelivery Sciences International, Inc. in conjunction with this event....

SA Transcripts on Seeking Alpha | September 15, 2020

My Pound The Table Moment For BioDelivery Sciences

Background BioDelivery Sciences (BDSI) is a biotechnology company focusing on an opioid, Belbuca, that is less addictive than most other opioids on the market. They also have a drug to treat opioid-induced constipation, marketed as SYMPROIC. You can learn more from my other two articles on BDSI here and here....

Matthew Zeets on Seeking Alpha | September 4, 2020

Earnings Preview: BioDelivery Sciences International (BDSI) Q2 Earnings Expected to Decline

BioDelivery (BDSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | July 29, 2020

Did Hedge Funds Make The Right Call On BioDelivery Sciences International, Inc. (BDSI) ?

At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming). In these volatile markets we scrutinize hedge fund filings to get a reading on which direction each stock might be going. […]

Yahoo | July 12, 2020

Hedge Funds Have Never Been This Bullish On BioDelivery Sciences International, Inc. (BDSI)

We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of March 31st, near the height of the coronavirus market crash. In this article, we look at what those funds think […]

Yahoo | June 10, 2020

Read More 'BDSI' Stories Here

BDSI Price Returns

1-mo 20.89%
3-mo -2.30%
6-mo -19.92%
1-year -43.99%
3-year 49.80%
5-year -36.96%
YTD -39.56%
2019 70.81%
2018 25.42%
2017 68.57%
2016 -63.47%
2015 -60.15%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8902 seconds.